Oncological Monitoring After Transanal Total Mesorectal Excision for Rectal Neoplasia

Authors

M Gachabayov, Section of Colorectal Surgery, Westchester Medical Center, New York Medical College, Valhalla, NY, USA.
R Bergamaschi, Section of Colorectal Surgery, Westchester Medical Center, New York Medical College, Valhalla, NY, USA.Follow
H Wasmuth, Department of Gastrointestinal Surgery, St Olav's Hospital, Trondheim University Hospital, Trondheim, Norway.
A Faerden, Department of Digestive Surgery, Akershus University Hospital, Akershus, Norway.
M Javadov, Department of Surgery, Yeditepe University Hospital, Istanbul, Turkey.
F Cianchi, Department of Surgery and Translational Medicine, Careggi Hospital, University of Florence, Florence, Italy.
M Barnajian, Division of Colorectal Surgery, Cedar Sinai Medical Center, Los Angeles, CA, USA.
D E. Popa, Department of Surgery, Linköping University Hospital, Linköping, Sweden.
H Lee, Division of Colon and Rectal Surgery, Harbor-UCLA Medical Center, Torrance, CA, USA. HLeea16bc@dhs.lacounty.gov.Follow

Author Type(s)

Resident/Fellow, Faculty

DOI

10.1007/s10151-023-02866-3

Journal Title

Techniques in Coloproctology

First Page

1411

Last Page

1412

Document Type

Article

Publication Date

12-1-2023

Department

Surgery

Recommended Citation

Gachabayov, M., Bergamaschi, R., Wasmuth, H., Faerden, A., Javadov, M., Cianchi, F., Barnajian, M., Popa, D. E., & Lee, H. (2023). Oncological Monitoring After Transanal Total Mesorectal Excision for Rectal Neoplasia. Techniques in Coloproctology, 27 (12), 1411-1412. https://doi.org/10.1007/s10151-023-02866-3